Skip to main content
Clinical Trials/EUCTR2019-001883-31-NL
EUCTR2019-001883-31-NL
Active, not recruiting
Phase 1

Microvascular Recovery using contrast Ultrasound in ST-elevation Myocardial Infarction in the ambulance (MRUSMI-Ambulance) - MRUSMI-Ambulance

VU Univesity Medical Center (VUmc)0 sites10 target enrollmentFebruary 25, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
ST elevation myocardial infarction
Sponsor
VU Univesity Medical Center (VUmc)
Enrollment
10
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 25, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
VU Univesity Medical Center (VUmc)

Eligibility Criteria

Inclusion Criteria

  • Patients presenting with STEMI with:
  • \-\= 2mm ST\-segment elevation in 2 anterior or lateral leads; or
  • \-\= 1 mm ST\-segment elevation in 2 inferior leads
  • \-\= 1mm ST\-segment elevation in lateral leads (I, aVL, V5, V6\)
  • \-Within 12 hours of symptom onset
  • \-Age \= 30 years
  • \-Adequate apical and/or parasternal images by echocardiography
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • \-Previous coronary bypass surgery
  • \-Cardiogenic shock
  • \-Known or suspected hypersensitivity to ultrasound contrast agent used for the study
  • \-Known bleeding diathesis or contraindication to glycoprotein IIB/IIIA inhibitors, anticoagulants or aspirin
  • \-Known large right to left intracardiac shunts

Outcomes

Primary Outcomes

Not specified

Similar Trials